Cannabis/cannabinoids withdrawal

Overview


Plain-Language Overview

Cannabis/cannabinoids withdrawal occurs when a person who regularly uses cannabis suddenly stops or reduces their intake. This condition primarily affects the nervous system, leading to a range of physical and psychological symptoms. Common signs include irritability, anxiety, sleep disturbances, and decreased appetite. These symptoms result from the brain's adjustment to the absence of cannabinoids, which normally interact with the endocannabinoid system to regulate mood and appetite. Withdrawal symptoms typically begin within a few days after cessation and can last up to two weeks. The condition can significantly impact daily functioning and well-being during this period.

Clinical Definition

Cannabis/cannabinoids withdrawal is a clinically recognized syndrome characterized by a constellation of symptoms that arise after abrupt cessation or reduction of prolonged and heavy cannabis use. The core pathology involves dysregulation of the endocannabinoid system, particularly decreased stimulation of CB1 receptors in the central nervous system. This leads to neurochemical imbalances affecting mood, sleep, and appetite regulation. The syndrome typically manifests within 24 to 72 hours after stopping cannabis and peaks within the first week. Major clinical features include irritability, anxiety, insomnia, decreased appetite, and restlessness. The condition is significant because it can contribute to relapse in individuals attempting to quit cannabis and may require supportive management.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.